rs121913246
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_000245.4(MET):āc.3689A>Gā(p.Tyr1230Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1230D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.3689A>G | p.Tyr1230Cys | missense_variant | 19/21 | ENST00000397752.8 | NP_000236.2 | |
MET | NM_001127500.3 | c.3743A>G | p.Tyr1248Cys | missense_variant | 19/21 | NP_001120972.1 | ||
MET | NM_001324402.2 | c.2399A>G | p.Tyr800Cys | missense_variant | 18/20 | NP_001311331.1 | ||
MET | XM_011516223.2 | c.3746A>G | p.Tyr1249Cys | missense_variant | 20/22 | XP_011514525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.3689A>G | p.Tyr1230Cys | missense_variant | 19/21 | 1 | NM_000245.4 | ENSP00000380860.3 | ||
MET | ENST00000318493.11 | c.3743A>G | p.Tyr1248Cys | missense_variant | 19/21 | 1 | ENSP00000317272.6 | |||
MET | ENST00000436117.3 | n.*1294A>G | non_coding_transcript_exon_variant | 18/20 | 1 | ENSP00000410980.2 | ||||
MET | ENST00000436117.3 | n.*1294A>G | 3_prime_UTR_variant | 18/20 | 1 | ENSP00000410980.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Papillary renal cell carcinoma type 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Mar 02, 2023 | This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 9140397, 34882875]. Functional studies indicate this variant impacts protein function [PMID: 9326629, 9826708, 10498872]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 1997 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2021 | The p.Y1248C variant (also known as c.3743A>G), located in coding exon 18 of the MET gene, results from an A to G substitution at nucleotide position 3743. The tyrosine at codon 1248 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant is reported in an individual with bilateral papillary renal cell carcinoma and gastric cancer (Schmidt L et al. Nat Genet, 1997 May;16:68-73). Functional studies indicate that the p.Y1248C alteration increases tyrosine kinase activity and confers cell transformation properties (Jeffers M et al. Proc Natl Acad Sci U S A, 1997 Oct;94:11445-50). Based on structural analysis, this variant is located in the tyrosine kinase domain and is mildly destabilizing to the local structure (Yuan H et al. Eur J Med Chem, 2018 Jan;143:491-502; Ambry internal data). This amino acid position is well conserved in available vertebrate species.This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Renal cell carcinoma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 23, 2021 | This variant has been observed in an individual with bilateral papillary renal carcinoma, stomach cancer, and rectal cancer (PMID: 9140397). ClinVar contains an entry for this variant (Variation ID: 13885). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this variant affects MET protein function (PMID: 9826708). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with cysteine at codon 1248 of the MET protein (p.Tyr1248Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at